GENERAL (Details) $ in Thousands		1 Months Ended	3 Months Ended		9 Months Ended		12 Months Ended
		Jul. 31, 2015 USD ($)	Mar. 31, 2016 USD ($)	Mar. 31, 2015 USD ($)	Mar. 31, 2016 USD ($) item	Mar. 31, 2015 USD ($)	Jun. 30, 2015 USD ($)
Organization Consolidation and Presentation of Financial Statements [Line Items]
Number of contract manufacturers | item					2
Number of vendors | item					2
Derivative financial instruments
Notional amount of derivative contract			$ 19,547		$ 19,547
Fair value of derivative assets current			854		854
Fair value of derivative liabilities current			5		5
Net derivative assets			849		849		$ 859
Prepaid expenses and other accounts receivable			18,613		18,613		32,645
Loss from hedging transactions recorded in general and administrative expenses			8		8
Loss from hedging transactions recorded in research and development expenses			18		18
Loss from hedging transactions recorded in sales and marketing expenses			11		11
Foreign exchange forward contracts	[1]		849		849		$ 859
Changes in unrealized gains, net of tax expense			668		745
Consideration paid for patents		$ 800			$ 800
Useful lives of patents					10 years
Amortization expenses			$ 21		$ 63
Accounts Payable [Member]
Organization Consolidation and Presentation of Financial Statements [Line Items]
Concentration risk (as a percent)					73.00%		79.00%

[1] Estimated to be reclassified into earnings during 2016.